Recent Renal News in Diabetes

• Pancreas uses taste receptors to sense fructose, study shows Feb. 7 According to the study, published online Feb. 6 by the Proceedings of the National Academy of Sciences, the beta cells respond to fructose by secreting insulin.
• FDA approves weekly diabetes therapy Bydureon Jan. 30 Amylin Pharmaceuticals and Alkermes' Bydureon, or exenatide, has been approved by the FDA as a once-weekly treatment for type 2 diabetes. The glucagonlike peptide-1 receptor agonist costs about $4,200 a year. Amylin is conducting an FDA-requested trial to determine whether Bydureon heightens the risk of heart attacks, thyroid cancer, and pancreatitis.
• Diet high in animal fat increases gestational diabetes risk Jan. 27 Women who consumed a diet high in animal fat and cholesterol before pregnancy were at higher risk for gestational diabetes than women whose diets were lower in animal fat and cholesterol, according to researchers at the National Institutes of Health and Harvard University.
• Fact sheet on diabetes available from National Institutes of Health Jan. 26 A new fact sheet from the National Institutes of Health explains the A1C test, a widely used and important test to diagnose type 2 diabetes and prediabetes, and to monitor blood glucose levels of people with type 1 and type 2 diabetes.
• Rare genetic disorder provides clues to development of the pancreas Jan. 23 The finding provides a clue to how it may be possible to program stem cells to become pancreatic cells.
• Study identifies new biomarkers for kidney failure in diabetes patients Jan. 20 High concentrations of Tumor Necrosis Factor Receptor 1 and 2 accurately predict the risk of renal function loss in Type 1 and in Type 2 diabetes ten years in advance, according to the study.

More Renal News

Recent Health Care News in Diabetes